Larry Brilliant on How Well We Are Fighting Covid-19
Three months ago, the epidemiologist weighed in on what we must do to defeat this new threat. We went back to ask: How are we doing, and what comes next?
Related Articles
AAN: Monoclonal Antibodies for MS During Breastfeeding Not Harmful
No association seen for mAb during breastfeeding with infant hospitalization, systemic antibiotic use, developmental delay.
PATHFNDR 1 Trial and Acromegaly
Monica Gadelha, DR, PhD, at the University of Rio De Janeiro discusses the PATHFNDR-1 trial and acromegaly.
Diagnosing Adult-Onset Leukoencephalopathy
Dr. La Piana gives advice to patients and caregivers on diagnosing adult onset leukoencephalopathy with axonal spheroids and pigmented glia.
FDA Approves Onivyde Combination for Metastatic Pancreatic Cancer
Approval allows Onivyde (plus oxaliplatin, fluorouracil, and leucovorin) as first-line therapy.
Tocilizumab in Multiple Myeloma Patients
Tyler Sandahl, MD, Clinical Pharmacist at the Mayo Clinic, discusses the use of Tocilizumab in multiple myeloma patients.
JAX Labratory and the Use of Mice in Rare Genetic Disease Testing
Cat Lutz, Ph.D., M.B.A. discusses how Jackson Laboratory uses mice in testing for human disease.Cat Lutz, Ph.D., M.B.A. Vice President of the Rare Disease Translational…
Acromegaly Research
Monica Gadelha, DR, PhD, University of Rio De Janeiro, discusses her acromegaly research.
2024 Orphan Drugs: PDUFA Dates and FDA Approvals
Almost half of all novel medications approved by the U.S. Food and Drug Administration (FDA) are orphan drugs. Below is the list of important regulatory…
Biliary Tract Cancer Treatment Options and the KEYNOTE-966 Trial
Robin Kate Kelley, MD, Professor of Clinical Medicine in the Division of Hematology/Oncology, University of California, San Francisco discusses treatment options for biliary tract cancers and…
Baylor Genetics Data at NORD, NSGC, and ASHG
Christine Eng, Chief Medical Officer at Baylor Genetics, discusses the information her company presented at various conferences.